AskBio taps industry vet for C-suite role in wake of Bayer deal

Fresh off of its acquisition by Bayer AG, Research Triangle Park-based Asklepios BioPharmaceutical Inc. has created a new C-suite position and tapped an industry veteran to fill it. Dr. Katherine High has been named president of therapeutics at AskBio and will also serve on its board of directors. She will be responsible for driving the strategic direction and execution of the company’s preclinical and clinical programs. AskBio, a clinical-stage adeno-associated virus (AAV ) gene therapy company,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news